MetaCap

Syndax Pharmaceuticals (SNDX) News

NASDAQ: SNDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.72-0.41 (-4.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SNDX news summary

We found 24 recent headlines mentioning Syndax Pharmaceuticals (SNDX): 0 in the past week and 13 in the past 30 days, most often from GlobeNewswire, Nasdaq, PR Newswire. For price context, SNDX is down 4.49% at $8.72. The most recent story, "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syndax Pharmaceuticals, Inc.- SNDX", was published by PR Newswire on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Syndax Pharmaceuticals headlines

Stocks mentioned alongside SNDX

Compare SNDX